Some Group employees receive compensation in the form of share-based payments, for which payment is made in equity instruments.
In accordance with IFRS 2 “Share-based Payments”, these plans are classified as equity-settled share-based payment transactions and, accordingly, the services compensated by these plans are recognized as an operating expense over the vesting period (i.e. the period in which the service and, where applicable, the performance conditions are fulfilled), with a corresponding entry recorded in shareholders' equity.
The services compensated by these plans are recognized as an expense, with the offset recognized in shareholders’ equity, over the vesting period. The amount of expense recognized in each period is determined by reference to the fair value of the equity instruments granted, as of the grant date.
The fair value of restricted shares is estimated at the date of grant based on the share price at that date after deductions for dividends on the shares that will not be paid to beneficiaries during the vesting period. The fair value of restricted shares subject to a performance condition based on Total Shareholder Return is estimated using a binomial model that takes into account the vesting conditions.
Each year, Sodexo reassesses the number of shares that are likely to be delivered to beneficiaries of restricted shares based on the applicable vesting conditions. The impact of any change in estimates is recognized in the income statement, with the offset recognized in shareholders’ equity.
Rules governing restricted share plans are as follows:
The performance criteria applied are directly linked to the Group's strategic priorities and are describes as follows:
The table below shows movements in restricted shares during the fiscal year:
not-included | FISCAL 2024 | FISCAL 2023 |
---|---|---|
Outstanding at the beginning of the fiscal year | 2,324,628 | 2,287,665 |
Granted during the fiscal year* | 1,360,745 | 852,820 |
Forfeited during the fiscal year | (397,427) | (478,279) |
Delivered during the fiscal year | (679,081) | (337,578) |
Outstanding at the end of the fiscal year | 2,608,865 | 2,324,628 |
* of which 497,626 shares corresponding to the beneficiaries rights adjusted as per the ratio calculated for the spin off Pluxee (ex Benefits & Rewards Services activity), (see note 3.2).
The weighted average fair value of the restricted shares granted in Fiscal 2024 is 65.45 euros per share (80.68 euros per share granted in Fiscal 2023).